These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17390091)

  • 21. Induction of insolubility by herpes simplex virus VP22 precludes intercellular trafficking of N-terminal Apoptin-VP22 fusion proteins.
    Rutjes SA; Bosma PJ; Rohn JL; Noteborn MH; Wesseling JG
    J Mol Med (Berl); 2003 Sep; 81(9):558-65. PubMed ID: 12879152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cells.
    Fang B; Xu B; Koch P; Roth JA
    Gene Ther; 1998 Oct; 5(10):1420-4. PubMed ID: 9930348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-tumor effect of lentivirus-mediated MUCI antibody-targeted gene therapy with VP22-TK system on MUC1(+) human ovarian cancer transplanted intraperitoneally in nude mice].
    Kong B; Wang W; Liu C; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Jiang S
    Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1207-10. PubMed ID: 12475412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer-specific targeting of an adenovirus-delivered herpes simplex virus thymidine kinase suicide gene using translational control.
    Mathis JM; Williams BJ; Sibley DA; Carroll JL; Li J; Odaka Y; Barlow S; Nathan CO; Li BD; DeBenedetti A
    J Gene Med; 2006 Sep; 8(9):1105-20. PubMed ID: 16802401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced effect of microdystrophin gene transfection by HSV-VP22 mediated intercellular protein transport.
    Xiong F; Xiao S; Yu M; Li W; Zheng H; Shang Y; Peng F; Zhao C; Zhou W; Chen H; Fang L; Chamberlain JS; Zhang C
    BMC Neurosci; 2007 Jul; 8():50. PubMed ID: 17617925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intercellular trafficking of VP22-GFP fusion proteins.
    Elliott G; O'Hare P
    Gene Ther; 1999 Jan; 6(1):149-51. PubMed ID: 10341888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the "bystander effect".
    Chen CY; Chang YN; Ryan P; Linscott M; McGarrity GJ; Chiang YL
    Hum Gene Ther; 1995 Nov; 6(11):1467-76. PubMed ID: 8573619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced green fluorescent protein fusion proteins of herpes simplex virus type 1 thymidine kinase and cytochrome P450 4B1: applications for prodrug-activating gene therapy.
    Steffens S; Frank S; Fischer U; Heuser C; Meyer KL; Dobberstein KU; Rainov NG; Kramm CM
    Cancer Gene Ther; 2000 May; 7(5):806-12. PubMed ID: 10830728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Herpes simplex virus VP22-human papillomavirus E2 fusion proteins produced in mammalian or bacterial cells enter mammalian cells and induce apoptotic cell death.
    Roeder GE; Parish JL; Stern PL; Gaston K
    Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):157-65. PubMed ID: 14709162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
    Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intercellular spread of GFP-VP22.
    Aints A; Dilber MS; Smith CI
    J Gene Med; 1999; 1(4):275-9. PubMed ID: 10738560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of VP22 spread in tissue culture.
    Brewis N; Phelan A; Webb J; Drew J; Elliott G; O'Hare P
    J Virol; 2000 Jan; 74(2):1051-6. PubMed ID: 10623773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poor intercellular transport and absence of enhanced antiproliferative activity after non-viral gene transfer of VP22-P53 or P53-VP22 fusions into p53 null cell lines in vitro or in vivo.
    Zavaglia D; Lin EH; Guidetti M; Pluquet O; Hainaut P; Favrot MC; Coll JL
    J Gene Med; 2005 Jul; 7(7):936-44. PubMed ID: 15754307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
    Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
    Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
    Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA
    Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracellular localization of Herpes simplex virus type 1 thymidine kinase fused to different fluorescent proteins depends on choice of fluorescent tag.
    Söling A; Simm A; Rainov N
    FEBS Lett; 2002 Sep; 527(1-3):153-8. PubMed ID: 12220652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroxyurea induces bystander cytotoxicity in cocultures of herpes simplex virus thymidine kinase-expressing and nonexpressing HeLa cells incubated with ganciclovir.
    Gentry BG; Boucher PD; Shewach DS
    Cancer Res; 2006 Apr; 66(7):3845-51. PubMed ID: 16585212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virion.
    Li J; Le L; Sibley DA; Mathis JM; Curiel DT
    Virology; 2005 Aug; 338(2):247-58. PubMed ID: 15996701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity.
    Rogulski KR; Kim JH; Kim SH; Freytag SO
    Hum Gene Ther; 1997 Jan; 8(1):73-85. PubMed ID: 8989997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular uptake of thymidine and antiherpetic drugs for thymidine kinase-deficient mutants of herpes simplex virus type 1.
    Bae PK; Kim JH; Kim HS; Chung IK; Paik SG; Lee CK
    Antiviral Res; 2006 Jul; 70(3):93-104. PubMed ID: 16546268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.